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techniques must be taken into account, in order to improve the 
results of TKA in this subgroup of patients.
Preoperative Considerations
1. Age and Activity
  RA patients are often younger (by approximately 10 or more 
years) than osteoarthritis (OA) patients at the time of TKA. 
The life span of RA patients with a knee replacement is not well 
known, however, assuming that RA patients have a normal life 
span, a TKA in this subgroup of patients on average needs to last 
longer and accordingly, the potential risk of late complications 
increases. Ranawat et al.
6) reported the results of 93 cemented 
TKAs in patients younger than 55 years, and there were 80% 
rheumatoid and 20% osteoarthritic knees in their series. Dalury 
et al.
7), in a series of 87 TKAs in patients younger than 45 years, 
reported that 87% of their patients had a diagnosis of RA or 
juvenile RA. In 1997, Gill et al.
8) also reported results of 68 
TKAs (52 patients) in patients younger than 55 years, and the 
diagnosis was osteoarthritis in 37 knees, rheumatoid arthritis in 
29 knees, and ankylosing spondylitis in 2 knees in their series. 
They found that all knees were rated as good or excellent for knee 
and function scores with an average follow-up period of 9.92 
years, and concluded that TKA performed in younger patients 
with OA and RA can attain results comparable to the excellent 
results obtained in the older age groups. However, because of the 
polyarticular involvement and decreased activity level in patients 
with RA, it is important to evaluate the functional activity of the 
knee based on physiological age rather than chronological age. 
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Introduction
  The knee is one of the most commonly affected joints in 
patients suffering from chronic rheumatoid arthritis (RA). 
The course of RA varies from mild disease to severe joint 
destructive variant that progresses rapidly, eventually leading 
to unremitting pain and joint deformity
1-3). Despite recent 
improvement in biological agents and treatment modalities in 
the field of rheumatology, progressive joint destruction continues 
to occur in a subgroup of RA patients, who eventually require 
joint surgery. In advanced disease, when synovectomy is of no 
benefit, total knee arthroplasty (TKA) has proven to be the most 
successful intervention that reduces knee pain and improves 
physical function in RA patients
4,5). However, as RA patients 
carry additional potential for late complications, many important 
considerations regarding preoperative evaluation and surgical 
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2. Multiple Joint Involvement
  RA is a chronic, systemic, and inflammatory disease, most 
often involving small peripheral joints, although many other 
synovial joints can be affected. Adult RA is usually polyarticular 
in nature, with a clinical picture characterized by synovitis and 
destruction of the affected joints. It is well known that up to 
half of RA patients suffering from knee pain have concomitant 
hip involvement
9). Eberhardt and Fex
10) reported 15% hip 
involvement at 1 year after onset of the disease, compared with 
28% at 5 years. There is controversy regarding the priority of 
joint surgery in patients with both joints affected in the same 
limb; however, in most cases, it is accepted that hip replacement 
should be undertaken before knee replacement, when both are 
indicated. The symptoms of these two conditions may overlap 
and pain relief obtained from hip replacement may delay knee 
replacement. The rehabilitation may be more tolerable after hip 
replacement even with significant ipsilateral knee involvement, 
whereas the converse is not always true. Additionally, adequate 
arc of hip motion is required for deep knee flexion, which is often 
required for successful TKA procedures. Conaty and Nickel
11) 
reported that, after successful hip and knee replacements, they 
were able to convert approximately 30% of class III and IV 
patients with combined hip and knee lesions to a more functional 
level.
  Cervical spine also needs careful attention in patients 
undergoing surgery. It is well known that RA involves cervical 
spine in three ways: basilar invagination, atlanto-axial instability, 
and subaxial instability. Collins et al.
12) reported that 61% of RA 
patients who have undergone knee or hip replacement were 
noted to have radiographic evidence of cervical spine instability 
in their study. Although surgical intervention is rarely needed, 
it is important to routinely check both flexion and extension on 
lateral cervical x-rays during preoperative evaluation, and pay 
special attention during intubation to avoid possible neurological 
compromise.
  Involvement of other joints, especially the ipsilateral ankle or 
contralateral knee or both, should be evaluated as it frequently 
precludes adequate rehabilitation. Upper-extremity involvement 
must also be evaluated prior to TKA. Frequently, in RA patients, 
involvement of shoulders, elbows and wrists precludes the use 
of assistive devices that are necessary for ambulation in the early 
postoperative period and, in such cases, the ability to rise from a 
seated position may depend solely on the individual’s legs
1,11).
3. Medication History
  Medications used in RA patients fall into three important 
categories: nonsteroidal anti-inflammatory drugs (NSAIDs), 
glucocorticoids and disease modifying antirheumatic drugs 
(DMARDs). DMARDs are comprised of drugs known 
as methotrexate, leflunomide, sulfasalazine, azathioprine, 
hydroxychloroquine, and the class of biologic response modifiers, 
including tumor necrosis factor alpha (TNF-α) inhibitor and 
interleukin-1 (IL-1) inhibitor
13-15).
  With the exception of newer cyclooxygenase (COX)-2 inhi-
bitors, most NSAIDs inhibit COX-1 and block formation of 
platelet-derived thromboxane A2, thus impairing thromboxane-
dependant platelet aggregation. Aspirin irreversibly blocks COX-
1, resulting in effective inhibition for the life span of platelet, 
whereas inhibition of COX-1 by traditional NSAIDs is reversible 
and can be restored, as the drug is cleared from circulation. 
In consideration of these factors, traditional NSAIDs should 
be discontinued for at least five half-lives for complete drug 
clearance prior to surgery, and aspirin should be discontinued 
for 7-10 days for the normal life span of platelet. Selective COX-
2 inhibitors (e.g., celecoxib) do not necessarily need to be 
discontinued, as they do not affect this mechanism of platelet 
inhibition
13,15).
  Chronic use of glucocorticoids is not uncommon in RA 
patients and, from the perspective of musculoskeletal system, the 
most concerned side-effects are related to bone quality, wound 
healing, and infection. The issue of perioperative dosing of 
glucocorticoids remains controversial and therefore, the current 
standard has been to individualize supplementation based on the 
magnitude of surgery and severity of illness
16,17). In their study, 
Shaw and Mandell
18) reported that, if supplemental “stress dose” 
steroids are prescribed, the dosage should be physiologic (i.e., 50-
100 mg every 8 hours), and immediately tapered to preoperative 
dose as soon as the patient is hemodynamically stable.
  In the perioperative period, the use of DMARDs, especially 
methotrexate, has been of concern because of possible fluid-
balance alterations and increased risk of perioperative in-
fection
13,15,18). However, in their prospective studies, both Perhala 
et al.
19) and Grennan et al.
20) recommended safe continuous 
use of methotrexate throughout the perioperative period. The 
perioperative use of methotrexate appears warranted but must 
be approached with a great deal of caution. As methotrexate and 
its metabolites are primarily excreted through the kidneys, it has 
been suggested to hold methotrexate the week before surgery 
and 1 to 2 weeks after in renally impaired individuals. According 
to the guidelines of the American College of Rheumatology
15) it 
has been recommended that biologic agents, such as abatacept, 
TNF-α inhibitor (e.g., etanercept), and rituximab, should not Knee Surg Relat Res, Vol. 24, No. 1, Mar. 2012    3
be used during the perioperative period, for at least 1 week 
prior to and 1 week after surgery. Perioperative medication 
recommendations for RA patients undergoing TKA are 
summarized in Table 1.
Intraoperative Considerations
1. Bone Quality
  Bone quality is generally poor in RA patients. This poor bone 
quality occurs due to the combined effect of inflammatory 
disease process itself and disuse and chronic use of steroids
1,16,17). 
Additionally, prostaglandin released by rheumatoid synovium 
has been suggested as an additive local deleterious factor because 
of its direct role in subchondral bone resorption
1). Poor bone 
integrity of subchondral bone is of particular concern, as the 
fixation and support of components (especially on tibial side) 
require adequate subchondral platform. For such reasons, in 
RA patients, cemented TKA is preferred over cementless or 
hybrid TKA
1,3,6). Secondary osteonecrosis around the knee 
may be found in the field of TKA in RA patients. The cause of 
secondary osteonecrosis is unknown. However, chronic steroid 
use or rheumatic disease itself may be the factors associated 
with secondary osteonecrosis. Depending on the extent of bony 
collapse, large uncontained bone defects can be filled with either 
bone graft or modular prosthesis augmentation. Additionally, 
the use of stem extensions and offset stem can assist component 
positioning and supplement fixation and reduce stress at the 
bone-implant interface.
  In addition to poor bone integrity of subchondral bone, it is 
not uncommon to confront with cyst formation in RA knees
1,3). 
These cysts often form contained defects with intact peripheral 
cortical rim, and can be very large in size. Such contained defects 
should be reconstructed either using autologous bone obtained at 
the time of surgery or allograft. 
2. Soft Tissue
  The involvement of soft tissue is a part of the pathology in RA; 
therefore, meticulous handling of soft tissue is essential. Although, 
there is little direct evidence that the underlying disease process 
in RA affects the skin condition in terms of wound healing, many 
authors have reported that RA patients usually have a greater 
risk of poor wound healing and late infections than OA patients. 
Medication (e.g., steroids) and poor nutrition often render these 
soft tissues atrophic. Attenuation of usual ligamentous restrains 
of the knee may occur, and in severe cases more constrained type 
of prosthesis may be required. Most often, however, a successful 
TKA can be performed using standard components. Valgus and 
varus deformities in RA patients are initially passively correctable. 
With time, however, a fixed varus or valgus deformity with 
flexion contracture develops
1,4,6,7).
  Severe flexion contracture may occur in patients with wheel-
chair dependency. Scott et al.
21) recommended that RA patients 
with severe flexion contracture should be treated by serial 
manipulation and casting in order to decrease the preoperative 
flexion contracture as much as possible. They also added that 
it is important to treat such a deformity by posterior soft tissue 
release, rather than simple removal of additional distal femoral 
bone. Correction of flexion contracture with increased distal 
femoral resection would elevate the joint line and may create 
mid-flexion instability. In contrast to OA patients in whom an 
almost complete resolution of flexion contracture is required 
at the time of surgery, RA patients undergoing TKA can be left 
Table 1. Perioperative Medication Recommendations for Rheumatoid Arthritis Patients
Medication Comments
NSAIDs Discontinue 5 half-lives before surgery. Aspirin should be stopped 7-10 days before surgery
Corticosteroids Individualized based on the magnitude of surgery and the severity of patient's illness
Methotrexate Continue perioperatively for all procedures. Consider withholding 1 to 2 doses for patients with poorly controlled diabetes; 
the elderly; and patients with liver, renal, or lung disease
Leflunomide Withhold 1-2 days before surgery and restart 1-2 weeks later or withhold 2 weeks before surgery and restart 3 days later
Sulfasalazine Withhold 1 day before surgery and restart 3 days later
Hydroxychloroquine Continue for all procedures
TNF antagonist Withhold etanercept for 1 week, and plan surgery for the end of the dosing interval for adalumimab and infliximab 
Restart 10-14 days postoperatively
IL-1 antagonist Withhold 1-2 days before surgery and restart 10 days postoperatively
NSAID: nonsteroidal anti-inflammatory drug, TNF: tumor necrosis factor, IL: interleukin.4    Lee and Choi. Total Knee Arthroplasty in Rheumatoid Arthritis
with approximately 1/3rd of the initial flexion contracture, when 
all other techniques to obtain full extension have failed but a 
large distal femoral resection is required thereby putting the 
collateral ligaments and popliteus tendon in danger, as the flexion 
contracture can be expected to resolve over time with physical 
therapy and continued loosening of the soft tissues
22). 
  Another deformity that may be present in chronically involved 
RA knee is fixed valgus. In fixed valgus knees, the lateral 
structures, including lateral collateral ligaments, iliotibial band, 
joint capsule and popliteus, are contracted with relative laxity 
of the medial structures. Adequate gradual lateral release is 
critical, since insufficient lateral release would tighten the lateral 
side, with relatively lax medial structure, and this may result in 
either recurrence or aggravation of valgus deformity after knee 
replacement. Correction of such deformity usually consists of 
gradual release, such as in the pie-crust technique, progressing 
from division of the iliotibial band to the lateral collateral 
ligament at its femoral origin
1,21).
  In RA patients, management of synovitis in the field of TKA 
has also been a concern. In the presence of active inflammatory 
synovitis, complete synovectomy is recommended, because 
recurrent synovitis after TKA may occur in this patient group, 
and complete synovectomy in such patients may lead to 
improvement in the patient’s general condition. However, limited 
synovectomy should be considered in the presence of inactive, 
quiet synovitis as it may induce fibrotic reaction.
3. Bone Deformities
  Correct rotational alignment of the femoral prosthesis is 
essential to achieving good outcome after TKA. Numerous 
anatomical studies have shown that the transepicondylar axis 
is a reliable rotational landmark. Posterior condyles can also be 
used as a rotational landmark since the posterior condyles can 
be easily identified intraoperatively. However, the anatomical 
features of the posterior condyles vary with deformity, which is 
often encountered in RA knees, adoption of posterior condyles 
as a rotational landmark can result in rotational malalignment 
of the femoral prosthesis. The lateral femoral condyle usually 
appears hypoplastic in valgus knees, and, in such cases, careful 
attention should be paid when determining the rotational axis of 
femoral prosthesis
1,23).
  Determining the level of tibial osteotomy could also be a 
problem in RA knees with valgus deformities, because of possible 
sinking of the lateral tibial condyle, and in such cases, positioning 
a 10 mm stylus at the usual highest position of the lateral tibial 
condyle can result in over resection. Therefore, it is essential to 
place the tip of the stylus, at a level higher than usual, on the 
imaginary convex lateral tibial plateau level. 
Clinical Results
  Long-term results of TKA for osteoarthritic and rheumatoid 
knees have been well documented. Up to 10 years of long-term 
results in RA patients have been reported by several authors, with 
survival rates of the prosthesis between 81% and 97.7%
6,7,24,25). 
Laskin and O’Flynn
4) used total condylar knee prosthesis for 
RA patients and reported survival rate of 81% at 10 years with 
revision surgery as the endpoint. There is still controversy 
whether to retain or sacrifice the posterior cruciate ligament 
(PCL) during the procedure, because of perceived attenuation 
of the ligament often noted in RA patients. Many authors also 
expressed concern that late failure of the PCL could lead to 
late posterior instability. Laskin and O’Flynn
4) reported 50% 
of instability in the sagittal plane after TKA using posterior 
cruciate retaining designs that resulted in increased revision 
rate. However, Scott et al.
21) argued that in more than 95% of 
RA patients undergoing TKA, the PCL was intact and should 
be preserved to maximize tibial rollback and subsequent knee 
flexion. Furthermore, Archibeck et al.
26) reported 95% good or 
excellent results in 46 RA knees treated with cruciate retaining 
TKA with a mean follow-up of 10.5 years.
  Choi et al. (Choong H. Choi, Unpublished data) reviewed 75 
TKAs (71 PCL-retaining, and 4 PCL-sacrificing designs) in 55 
RA patients with a minimum 15-year follow-up, and reported an 
implant survival rate of 85.5% at 15 years and 79.0% at 19 years. 
They found a significant increase in the incidence of revision 
due to loosening of the prostheses after 10 years of follow-up, 
occurring at an average of 12.4 years (range, 3 to 16 years).
  Only few studies have compared the outcome of TKA in OA 
and RA knees. In a study with an equal number of OA and RA 
knees, van Loon et al.
27) reported prosthesis survival rate of 90% 
at 10 years. However, TKA for RA and that for OA were not 
similar in terms of the activity of patients, osteoporosis around 
the knee, disorder of other joints and age at surgery. Therefore, 
the data of follow-up results for the two conditions were not 
exactly comparable if the prosthesis, disease population and age 
at surgery were considered. Gill et al.
8) compared the clinical 
results of TKA between RA (30 knees) and OA (37 knees) 
patients with an average follow-up period of 9.9 years, and 
reported that the results were good to excellent in all knees in 
terms of pain relief, range of motion, and knee stability, however, 
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inferior in OA patients.
Complications
  Complications after TKA can be more frequent and serious 
in RA patients than OA patients, because of poor healing 
nature of soft tissue, higher rate of deep wound infection, 
severe preoperative joint deformity and laxity, poor bone stock 
and involvement of other multiple joints precluding adequate 
rehabilitation. The most important complication affecting the 
results of TKA in RA patients could be deep wound infection. 
Rates of infection have been reported to be three times higher in 
RA patients compared to OA patients
28,29). Although other reports 
have documented favorable infection rates after TKA, Rodriguez 
et al.
30) found delayed (average of 7 years) infection in 4.1% of RA 
patients who had undergone primary TKA. The reasons for this 
are multifactorial, but it has been suggested that corticosteroids, 
rather than the disease process itself, may be responsible.
  Rheumatoid arthritis and chronic steroid use have been 
associated with an increased risk of periprosthetic fracture 
because of poor bone quality. However, it is unclear whether 
steroid use is a risk factor or an indicator of the severity of disease 
itself. Bogoch and Moran
23) reported in their series of 16 patients 
with supracondylar periprosthetic fracture that 12 had RA, 10 of 
which were chronic steroid users. Choi et al. (Choong H. Choi, 
Unpublished Data), in their study of 75 TKAs in 55 RA patients 
with a minimum 15-year follow-up, found a significant increase 
in the incidence of supracondylar periprosthetic fracture at an 
average of 11.9 years after surgery (range, 9 to 14 years).
Conclusions
 
  TKA has been established as one of the most successful surgical 
interventions for reducing pain and enhancing physical function 
in RA patients. It is crucial to understand the systemic nature 
of RA since patients with RA often have additional medical, 
anesthetic, and multiple musculoskeletal problems when 
compared to patients with OA. Complications following TKA 
may be more frequent and serious in RA patients because of poor 
healing nature of soft tissue, higher rate of deep wound infection, 
severe preoperative joint deformity and laxity, poor bone stock, 
and involvement of other multiple joints that precludes adequate 
rehabilitation. Despite such complexities often encountered in 
RA patients, a well-timed, well executed TKA has been proven 
to improve overall function and quality of life of patients with 
disabling RA of the knee.
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